Acyldepsipeptide Analogues: A Future Generation Antibiotics for Tuberculosis Treatment
Acyldepsipeptides (ADEPs) are a new class of emerging antimicrobial peptides (AMPs), which are currently explored for treatment of pathogenic infections, including tuberculosis (TB). These cyclic hydrophobic peptides have a unique bacterial target to the conventional anti-TB drugs, and present a the...
Main Authors: | Sinazo Z. Z. Cobongela, Maya M. Makatini, Phumlane S. Mdluli, Nicole R. S. Sibuyi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-09-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/14/9/1956 |
Similar Items
-
Design and synthesis of Acyldepsipeptide-1 analogues: Antibacterial activity and cytotoxicity screening
by: Sinazo Z.Z. Cobongela, et al.
Published: (2023-08-01) -
Antibacterial Activity and Cytotoxicity Screening of Acyldepsipeptide-1 Analogues Conjugated to Silver/Indium/Sulphide Quantum Dots
by: Sinazo Z. Z. Cobongela, et al.
Published: (2024-02-01) -
Antibiotic Acyldepsipeptides Stimulate the Streptomyces Clp-ATPase/ClpP Complex for Accelerated Proteolysis
by: Laura Reinhardt, et al.
Published: (2022-12-01) -
Mycobacterial Caseinolytic Protease Gene Regulator ClgR Is a Substrate of Caseinolytic Protease
by: Yoshiyuki Yamada, et al.
Published: (2017-04-01) -
Metal–Peptide Complexes as Promising Antibiotics to Fight Emerging Drug Resistance: New Perspectives in Tuberculosis
by: Concetta Di Natale, et al.
Published: (2020-06-01)